Logo image of TDOC

TELADOC HEALTH INC (TDOC) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:TDOC - US87918A1051 - Common Stock

6.29 USD
-0.04 (-0.63%)
Last: 1/26/2026, 8:26:48 PM
6.2999 USD
+0.01 (+0.16%)
After Hours: 1/26/2026, 8:26:48 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TDOC. TDOC was compared to 34 industry peers in the Health Care Technology industry. TDOC has a bad profitability rating. Also its financial health evaluation is rather negative. TDOC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • TDOC had negative earnings in the past year.
  • TDOC had a positive operating cash flow in the past year.
  • In the past 5 years TDOC always reported negative net income.
  • TDOC had a positive operating cash flow in 4 of the past 5 years.
TDOC Yearly Net Income VS EBIT VS OCF VS FCFTDOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -7.75%, TDOC is in line with its industry, outperforming 58.82% of the companies in the same industry.
  • TDOC's Return On Equity of -16.03% is fine compared to the rest of the industry. TDOC outperforms 64.71% of its industry peers.
Industry RankSector Rank
ROA -7.75%
ROE -16.03%
ROIC N/A
ROA(3y)-115.95%
ROA(5y)-70.6%
ROE(3y)-222.82%
ROE(5y)-134.84%
ROIC(3y)N/A
ROIC(5y)N/A
TDOC Yearly ROA, ROE, ROICTDOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

1.3 Margins

  • With a decent Gross Margin value of 69.80%, TDOC is doing good in the industry, outperforming 73.53% of the companies in the same industry.
  • In the last couple of years the Gross Margin of TDOC has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for TDOC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y1.2%
TDOC Yearly Profit, Operating, Gross MarginsTDOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

3

2. Health

2.1 Basic Checks

  • TDOC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TDOC has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TDOC has more shares outstanding
  • The debt/assets ratio for TDOC is higher compared to a year ago.
TDOC Yearly Shares OutstandingTDOC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
TDOC Yearly Total Debt VS Total AssetsTDOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of -6.57, we must say that TDOC is in the distress zone and has some risk of bankruptcy.
  • TDOC's Altman-Z score of -6.57 is on the low side compared to the rest of the industry. TDOC is outperformed by 79.41% of its industry peers.
  • The Debt to FCF ratio of TDOC is 7.10, which is on the high side as it means it would take TDOC, 7.10 years of fcf income to pay off all of its debts.
  • TDOC has a Debt to FCF ratio of 7.10. This is comparable to the rest of the industry: TDOC outperforms 55.88% of its industry peers.
  • A Debt/Equity ratio of 0.71 indicates that TDOC is somewhat dependend on debt financing.
  • TDOC has a Debt to Equity ratio of 0.71. This is in the lower half of the industry: TDOC underperforms 79.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 7.1
Altman-Z -6.57
ROIC/WACCN/A
WACC6.86%
TDOC Yearly LT Debt VS Equity VS FCFTDOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

  • TDOC has a Current Ratio of 2.70. This indicates that TDOC is financially healthy and has no problem in meeting its short term obligations.
  • TDOC has a Current ratio (2.70) which is comparable to the rest of the industry.
  • TDOC has a Quick Ratio of 2.60. This indicates that TDOC is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.60, TDOC is in line with its industry, outperforming 58.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.7
Quick Ratio 2.6
TDOC Yearly Current Assets VS Current LiabilitesTDOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

  • The earnings per share for TDOC have decreased strongly by -13.27% in the last year.
  • The Revenue has decreased by -2.37% in the past year.
  • TDOC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.95% yearly.
EPS 1Y (TTM)-13.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.37%
Revenue 1Y (TTM)-2.37%
Revenue growth 3Y8.13%
Revenue growth 5Y35.95%
Sales Q2Q%-2.2%

3.2 Future

  • Based on estimates for the next years, TDOC will show a small growth in Earnings Per Share. The EPS will grow by 6.70% on average per year.
  • Based on estimates for the next years, TDOC will show a small growth in Revenue. The Revenue will grow by 1.86% on average per year.
EPS Next Y2.5%
EPS Next 2Y16.95%
EPS Next 3Y12.56%
EPS Next 5Y6.7%
Revenue Next Year-1.79%
Revenue Next 2Y-0.4%
Revenue Next 3Y0.38%
Revenue Next 5Y1.86%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TDOC Yearly Revenue VS EstimatesTDOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
TDOC Yearly EPS VS EstimatesTDOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 -10 -20 -30 -40 -50

3

4. Valuation

4.1 Price/Earnings Ratio

  • TDOC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TDOC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TDOC Price Earnings VS Forward Price EarningsTDOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TDOC is valued cheaply inside the industry as 91.18% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, TDOC is valued cheaply inside the industry as 94.12% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.97
EV/EBITDA 7.68
TDOC Per share dataTDOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TDOC's earnings are expected to grow with 12.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.95%
EPS Next 3Y12.56%

0

5. Dividend

5.1 Amount

  • TDOC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

TELADOC HEALTH INC / TDOC FAQ

What is the ChartMill fundamental rating of TELADOC HEALTH INC (TDOC) stock?

ChartMill assigns a fundamental rating of 3 / 10 to TDOC.


What is the valuation status for TDOC stock?

ChartMill assigns a valuation rating of 3 / 10 to TELADOC HEALTH INC (TDOC). This can be considered as Overvalued.


How profitable is TELADOC HEALTH INC (TDOC) stock?

TELADOC HEALTH INC (TDOC) has a profitability rating of 2 / 10.


How financially healthy is TELADOC HEALTH INC?

The financial health rating of TELADOC HEALTH INC (TDOC) is 3 / 10.